Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,305 | -4,353 | -1,960 | 0 | -13,074 |
| Depreciation Amortization | 58 | 38 | 19 | 0 | 34 |
| Accounts receivable | -40 | N/A | -72 | N/A | N/A |
| Accounts payable and accrued liabilities | -466 | -444 | -243 | N/A | -241 |
| Other Working Capital | -737 | -569 | -224 | 0 | -460 |
| Other Operating Activity | 1,916 | 1,044 | 575 | 0 | 10,043 |
| Operating Cash Flow | $-6,574 | $-4,284 | $-1,904 | $0 | $-3,698 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32 | -2 | N/A | 0 | -66 |
| Investing Cash Flow | $-32 | $-2 | $0 | $0 | $-66 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -3 | N/A | 8,358 |
| Common Stock Issued | 11,587 | 11,527 | 5,000 | N/A | -63 |
| Other Financing Activity | -27 | -3 | 0 | 0 | -968 |
| Financing Cash Flow | $11,560 | $11,524 | $4,997 | $0 | $7,327 |
| Beginning Cash Position | 4,036 | 4,036 | 4,036 | 0 | 261 |
| End Cash Position | 8,991 | 11,274 | 7,129 | 0 | 3,824 |
| Net Cash Flow | $4,954 | $7,238 | $3,093 | $0 | $3,563 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,574 | -4,284 | -1,904 | 0 | -3,698 |
| Capital Expenditure | -32 | -2 | 0 | N/A | -66 |
| Free Cash Flow | -6,606 | -4,286 | -1,904 | 0 | -3,764 |